1. Jones RN, Kugler KC, Pfaller MA, Winokur PL. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis. 1999; 35:55–63. PMID:
10529882.
Article
2. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol. 2009; 12:476–481. PMID:
19716760.
Article
3. Cocchi S, Grasselli E, Gutacker M, Benagli C, Convert M, Piffaretti JC. Distribution and characterization of integrons in
Escherichia coli strains of animal and human origin. FEMS Immunol Med Microbiol. 2007; 50:126–132. PMID:
17456180.
4. Sandalli C, Buruk CK, Sancaktar M, Ozgumus OB. Prevalence of integrons and a new
dfrA17 variant in Gram-negative bacilli that cause community-acquired infections. Microbiol Immunol. 2010; 54:164–169. PMID:
20236427.
5. National Committee for Clinical Laboratory Standards. Tenth Informational supplement, M100-S10 (M2). Performance standards for antimicrobial susceptibility testing. Wayne, PA: National Committee for Clinical Laboratory Standards;2000.
6. Lévesque C, Piché L, Larose C, Roy PH. PCR Mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995; 39:185–191. PMID:
7695304.
Article
7. White PA, McIver CJ, Rawlinson WD. Integrons and gene cassettes in the enterobacteriaceae. Antimicrob Agents Chemother. 2001; 45:2658–2661. PMID:
11502548.
9. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC Jr, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990; 34:2193–2199. PMID:
2073110.
10. Versalovic J, Schneider M, de Bruijn FJ, Lupski JR. Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol Cell Biol. 1994; 5:25–40.
11. Seurinck S, Verstraete W, Siciliano SD. Use of 16S-23S rRNA intergenic spacer region PCR and repetitive extragenic palindromic PCR analyses of
Escherichia coli isolates to identify nonpoint fecal sources. Appl Environ Microbiol. 2003; 69:4942–4950. PMID:
12902290.
12. El-Najjar NG, Farah MJ, Hashwa FA, Tokajian ST. Antibiotic resistance patterns and sequencing of class I integron from uropathogenic
Escherichia coli in Lebanon. Lett Appl Microbiol. 2010; 51:456–461. PMID:
20840552.
13. Sawma-Aouad G, Hashwa F, Tokajian S. Antimicrobial resistance in relation to virulence determinants and phylogenetic background among uropathogenic
Escherichia coli in Lebanon. J Chemother. 2009; 21:153–158. PMID:
19423467.
14. Ozgumus OB, Celik-Sevim E, Alpay-Karaoglu S, Sandalli C, Sevim A. Molecular characterization of antibiotic resistant
Escherichia coli strains isolated from tap and spring waters in a coastal region in Turkey. J Microbiol. 2007; 45:379–387. PMID:
17978796.
15. Ozgumus OB, Sandalli C, Sevim A, Celik-Sevim E, Sivri N. Class 1 and class 2 integrons and plasmid-mediated antibiotic resistance in coliforms isolated from ten rivers in northern Turkey. J Microbiol. 2009; 47:19–27. PMID:
19229487.
Article
16. Solberg OD, Ajiboye RM, Riley LW. Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic
Escherichia coli. J Clin Microbiol. 2006; 44:1347–1351. PMID:
16597861.
17. Jones LA, McIver CJ, Rawlinson WD, White PA. Polymerase chain reaction screening for integrons can be used to complement resistance surveillance programs. Commun Dis Intell Q Rep. 2003; 27(Suppl):S103–S110. PMID:
12807284.
18. Leverstein-van Hall MA, Box AT, Blok HE, Paauw A, Fluit AC, Verhoef J. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis. 2002; 186:49–56. PMID:
12089661.
Article